» Articles » PMID: 19822975

Mechanisms of Remodelling: a Question of Life (stem Cell Production) and Death (myocyte Apoptosis)

Overview
Journal Circ J
Date 2009 Oct 14
PMID 19822975
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Remodeling myocytes show a typical switch between the embryonic and classical features of apoptosis and/or hypertrophy representing a signal of death (ie, apoptosis) and a signal of life (ie, hypertrophy). The adult myocyte, however, is a terminal cell; usually it is unable to reproduce and death is not genetically programmed (apoptosis), but occurs by necrosis. The reinstatement of apoptosis and development of hypertrophy during remodeling could be part of the switch forward to the embryonic phenotype with reinstatement of the early embryonic genetic program. Hypertrophy and apoptosis are "sons" of the same "mother": the local, tissue neuroendocrine-neurohumoral response to a mechanical stretch of the myocytes consequent to the geometric changes imposed on the viable myocytes by the necrotic ones. As expected, the life and death cycle is very closely regulated by several autocrine systems, one of which is linked to the interleukin-6 family via a regulatory protein named GP-130. Activation of the GP-130 slows down the death signals, thus favoring hypertrophy and reducing fibrosis.

Citing Articles

Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Forrester S, Booz G, Sigmund C, Coffman T, Kawai T, Rizzo V Physiol Rev. 2018; 98(3):1627-1738.

PMID: 29873596 PMC: 6335102. DOI: 10.1152/physrev.00038.2017.


The exon junction complex senses energetic stress and regulates contractility and cell architecture in cardiac myocytes.

Pierrat O, Paudyal A, Woodruff J, Koroleva O, Boateng S Biosci Rep. 2017; 37(4).

PMID: 28566540 PMC: 6434082. DOI: 10.1042/BSR20170707.


Frequency of early remodeling of left ventricle and its comparison between patients with stroke volume ≥97 Ml versus patients with stroke volume <97 Ml after aortic valve replacement for severe aortic regurgitation.

Farhan Ali Rizvi H, Khalid Z, Baksh A, Baig M Pak J Med Sci. 2017; 32(6):1360-1363.

PMID: 28083026 PMC: 5216282. DOI: 10.12669/pjms.326.11173.


Current views on anthracycline cardiotoxicity.

Mele D, Nardozza M, Spallarossa P, Frassoldati A, Tocchetti C, Cadeddu C Heart Fail Rev. 2016; 21(5):621-34.

PMID: 27230651 DOI: 10.1007/s10741-016-9564-5.


Heart rate reduction in coronary artery disease and heart failure.

Ferrari R, Fox K Nat Rev Cardiol. 2016; 13(8):493-501.

PMID: 27226153 DOI: 10.1038/nrcardio.2016.84.